Leslie, William D. http://orcid.org/0000-0002-1056-1691
Möller, Sören
Skjødt, Michael K.
Yan, Lin
Abrahamsen, Bo
Lix, Lisa M.
McCloskey, Eugene V.
Johansson, Helena
Harvey, Nicholas C.
Kanis, John A.
Rubin, Katrine Hass
Article History
Received: 12 October 2021
Accepted: 13 February 2022
First Online: 17 February 2022
Declarations
:
: Michael K. Skjødt: educational grant, UCB and institutional research grant, UCB/Amgen.Eugene McCloskey: nothing to declare for the context of this paper, but numerous ad hoc consultancies/speaking honoraria and/or research funding from Amgen, Bayer, General Electric, GSK, Fresenius Kabi, Hologic, Lilly, Merck Research Labs, Novartis, Novo Nordisk, Nycomed, Ono, Pfizer, ProStrakan, Roche, Sanofi-Aventis, Servier, Tethys, UCB and Warner-Chilcott.Nicholas Harvey: nothing to declare for the context of this paper, but has received consultancy/lecture fees/honoraria/grant funding from Alliance for Better Bone Health, Amgen, MSD, Eli Lilly, Servier, Shire, UCB, Consilient Healthcare, Radius Health, Kyowa Kirin and Internis Pharma.Bo Abrahamsen: institutional research contracts with Novartis, UCB, Kyowa-Kirin. Fees or honoraria from UCB, Amgen, Pharmacosmos.William Leslie, Lisa Lix, Lin Yan, Helena Johansson, John Kanis, Sören Möller, Katrine Hass Rubin: no conflicts of interest.